These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 6713398

  • 1. Biochemical and morphological characterization of clonal AXC rat prostate cancer cells.
    Shain SA, Huot RI, Gorelic LS, Smith GC.
    Cancer Res; 1984 May; 44(5):2033-42. PubMed ID: 6713398
    [Abstract] [Full Text] [Related]

  • 2. Differential androgen modulation of AXC/SSh rat prostate cancer cell proliferation in vitro and its antagonism by antiandrogen.
    Huot RI, Shain SA.
    Cancer Res; 1986 Aug; 46(8):3775-81. PubMed ID: 2942235
    [Abstract] [Full Text] [Related]

  • 3. A x C rat prostate adenocarcinoma: initial characterization of testosterone regulation of hormone receptors of cultured cancer cells and derived tumors.
    Shain SA, Boesel RW, Kalter SS, Heberling RL.
    J Natl Cancer Inst; 1981 Mar; 66(3):565-74. PubMed ID: 6259402
    [Abstract] [Full Text] [Related]

  • 4. Proliferation of AXC/SSh rat prostate cancer cells in vitro is androgen modulated.
    Shain SA, Huot RI.
    J Steroid Biochem; 1987 Mar; 27(1-3):503-12. PubMed ID: 3320541
    [Abstract] [Full Text] [Related]

  • 5. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 Mar; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
    Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R.
    Cancer Res; 1995 Oct 01; 55(19):4438-45. PubMed ID: 7671257
    [Abstract] [Full Text] [Related]

  • 9. Differences in responsiveness of clonally derived AXC/SSh rat prostate cancer cells to secreted or prototypic mitogens.
    Shain SA, Koger JD.
    Cancer Res; 1989 Jul 15; 49(14):3898-903. PubMed ID: 2786746
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
    Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR.
    Cancer Res; 2001 Nov 15; 61(22):8135-42. PubMed ID: 11719442
    [Abstract] [Full Text] [Related]

  • 13. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.
    Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB.
    Cancer Res; 1994 Jul 01; 54(13):3413-21. PubMed ID: 8012960
    [Abstract] [Full Text] [Related]

  • 14. Hormone regulation of human prostate in organ culture.
    Nevalainen MT, Härkönen PL, Valve EM, Ping W, Nurmi M, Martikainen PM.
    Cancer Res; 1993 Nov 01; 53(21):5199-207. PubMed ID: 7693334
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
    Gu Y, Kim KH, Ko D, Nakamura K, Yasunaga Y, Moul JW, Srivastava S, Arnstein P, Rhim JS.
    Int J Oncol; 2004 Oct 01; 25(4):1057-64. PubMed ID: 15375556
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.